| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/23/2006 | EP1693382A2 Melanocortin 1 receptor selective compounds |
| 08/23/2006 | EP1692518A2 Detection of protein interactions |
| 08/23/2006 | EP1692187A1 Ec sod and cell transducing ec sod and use thereof |
| 08/23/2006 | EP1692186A1 Cancer cell targeting gene delivery method |
| 08/23/2006 | EP1692162A2 Tool for the transfer and production of proteins using the pseudomonas type iii secretion system |
| 08/23/2006 | EP1692160A2 Fgf-5 binding and supported peptides |
| 08/23/2006 | EP1692159A2 Tgf-beta binding and supported peptides |
| 08/23/2006 | EP1692158A2 Tgf-beta binding and supported peptides |
| 08/23/2006 | EP1240337B1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 08/23/2006 | CN1270775C Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 08/22/2006 | US7094599 Therapeutic cells which express a membrane-bound, chimeric, proteinaceous receptor comprising an extracellular CD4 fragment to bind an HIV-infected cell without contracting the infection and an intracellular portion to destroy it |
| 08/22/2006 | US7094577 Insulin and albumin fusion protein |
| 08/22/2006 | US7094548 Polypeptide for use in purifying and separation of target peptides |
| 08/22/2006 | US7094409 Antigen arrays for treatment of allergic eosinophilic diseases |
| 08/22/2006 | US7094407 Self cell-penetrating Tat peptide having a self penetrating signal is bound to a human Type-I collagen C-terminal derived peptide |
| 08/22/2006 | US7094405 Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients |
| 08/17/2006 | WO2006085583A1 Cell permeable peptide |
| 08/17/2006 | WO2006084337A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | WO2006084327A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | WO2006084319A1 Immunogenic molecules |
| 08/17/2006 | WO2006061650A3 Methods, products and uses involving platelets and/or the vasculature |
| 08/17/2006 | WO2006059093A3 Fusion proteins |
| 08/17/2006 | US20060183209 Fusion protein for use in genration of preferential biopolymers in plants |
| 08/17/2006 | US20060183192 Modulation of sodium channels in dorsal root ganglia |
| 08/17/2006 | US20060183177 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 08/17/2006 | US20060182755 Novel composition and methods for the treatment of psoriasis |
| 08/17/2006 | CA2597346A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | CA2597008A1 Immunogenic molecules |
| 08/16/2006 | EP1690935A2 Generation of xenogeneic antibodies |
| 08/16/2006 | EP1690934A2 Generation of xenogeneic antibodies |
| 08/16/2006 | EP1689783A2 Mutated anti-cd22 antibodies and immunoconjugates |
| 08/16/2006 | EP1297013B1 Use of taci as an anti-tumor agent |
| 08/16/2006 | EP1268530B1 Hepatitis b core antigen fusion proteins |
| 08/16/2006 | EP1252192B1 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/16/2006 | EP1115876B1 Receptor based antagonists and methods of making and using |
| 08/16/2006 | CN1818069A Preparation of genetic recombinant fusion protein PFK-K5 |
| 08/16/2006 | CN1818067A Zoophobous fusion protein and use thereof |
| 08/16/2006 | CN1818066A Food-poisoning fungus concatenated fusion mycinamicin and use thereof |
| 08/16/2006 | CN1817909A Double-functional blended protein |
| 08/16/2006 | CN1817908A Recombinant solvent protein derivative, its production and use |
| 08/16/2006 | CN1817907A Recombinant solvent protein, its production and use |
| 08/16/2006 | CN1817902A Recombinant scorpion toxin, its soluble expression and purification |
| 08/16/2006 | CN1817367A Activation and inhibition of the immune system |
| 08/16/2006 | CN1269958C Zinc finger binding domains for GNN |
| 08/16/2006 | CN1269840C Human interferon analogue with long-lasting biological effects |
| 08/15/2006 | US7091326 Fusion protein having enhanced in vivo erythropoietin activity |
| 08/15/2006 | US7091325 Fibrin/fibrinogen-binding conjugate |
| 08/15/2006 | US7091321 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/15/2006 | US7091317 Enhanced green fluorescent protein for use as diagnostic tool in monitoring gene expression, function and localization |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7090843 immunotherapy; fusion proteins; antitumor agents; for treatment and prevention of hodgkin's disease |
| 08/15/2006 | US7090842 antigen-binding fragment comprises immunoglobulin variable region light chains and heavy chains, produced by hybridoma; fusion proteins |
| 08/10/2006 | WO2006082992A1 Method of constructing novel higher plant and mehtod of promoting the growth of higher plant |
| 08/10/2006 | WO2006082406A2 Human antibodies and proteins |
| 08/10/2006 | US20060179493 Transgenically produced non-secreted proteins |
| 08/10/2006 | US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 08/10/2006 | US20060177461 Stress proteins and uses therefor |
| 08/10/2006 | US20060177460 Administering to a patient a stress protein joined via a peptide bond to a melanoma antigen to induce or enhanc an immune response against the melanoma antigen |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | CA2597040A1 Hiv tat-cd4 hybrid molecules and methods of use thereof |
| 08/10/2006 | CA2596929A1 T cd4+ epitopes of type i and ii latency antigens of the epstein-barr virus, which can be recognised by the majority of individuals in the caucasian population and applications thereof |
| 08/10/2006 | CA2596833A1 Human antibodies and proteins |
| 08/10/2006 | CA2596661A1 Novel hydrophobin fusion products, production and use thereof |
| 08/10/2006 | CA2596514A1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 08/10/2006 | CA2595904A1 Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders |
| 08/10/2006 | CA2583306A1 Use of rna trans-splicing for antibody gene transfer and antibody polypeptide production |
| 08/09/2006 | EP1688439A1 Fused protein composition |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1687339A2 Fusion proteins and detergent compositions comprising them |
| 08/09/2006 | EP1687338A1 Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor |
| 08/09/2006 | EP1687017A2 Methods and compositions for delivering polynucleotides |
| 08/09/2006 | EP1549951A4 Semaphorin-like proteins and methods of using same |
| 08/09/2006 | CN1814619A Chimeric antigen for preventing, diagnozing and treating respiratory syncytial virus infection and its antibody |
| 08/09/2006 | CN1268753C Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/09/2006 | CN1268741C Therapy for 'alpha'-galactosidase deficiency |
| 08/09/2006 | CN1268645C Therapeutic compounds comprised of anti-FC receptor binding agents |
| 08/09/2006 | CN1268641C 载脂蛋白类似物 Apolipoprotein analogues |
| 08/09/2006 | CN1268394C Binding domain-immunoglobulin fusion proteins |
| 08/08/2006 | US7087811 Enhanced protein production in higher plants by N-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
| 08/08/2006 | US7087726 Anti-interferon-α antibodies |
| 08/08/2006 | US7087716 Regulator of G protein signalling |
| 08/08/2006 | US7087711 Activators comprise a DNA binding moiety linked to a hydrophobic peptide; useful for the identification and characterization of protein-protein interactions |
| 08/08/2006 | US7087224 Method of treating anemia by administering IL-1ra |
| 08/08/2006 | CA2071875C Recombinant human factor viii derivative |
| 08/03/2006 | WO2006080837A2 Means and methods for breaking noncovalent binding interactions between molecules |
| 08/03/2006 | WO2006079176A1 Molecules and chimeric molecules thereof |
| 08/03/2006 | WO2006054096A3 Soluble bifunctional proteins |
| 08/03/2006 | US20060173166 Protein lattice |
| 08/03/2006 | US20060172380 TAB1 protein and DNA coding therefore |
| 08/03/2006 | US20060172363 Peptide complexes containing phospholipase d |
| 08/03/2006 | US20060172298 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 08/03/2006 | US20060171965 Fusion proteins of mycobacterium tuberculosis |
| 08/03/2006 | US20060171954 Antigen specific activated T-lymphocytes, detection and use |
| 08/03/2006 | CA2596537A1 Molecules and chimeric molecules thereof |
| 08/03/2006 | CA2595727A1 Means and methods for breaking noncovalent binding interactions between molecules |
| 08/02/2006 | EP1686379A1 Fluorescence indicator utilizing fret |
| 08/02/2006 | EP1685847A1 Beta-amyloid-analogue-T-cell epitop vaccine |
| 08/02/2006 | EP1420815B1 Beta-amyloid-analogue - t-cell epitop vaccine |
| 08/02/2006 | EP0914339B1 RET LIGAND 3 (RetL3) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 08/02/2006 | CN1813188A Diagnosis of carcinomas |